RxE2 Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and Marketplace

Press Releases

FARGO, N.D., Dec. 4, 2023 /PRNewswire/ — RxE2, the pioneer in pharmacy-led medical innovation, announces the launch of a groundbreaking technology platform that redefines the clinical trial landscape. RxE2 is the first technology company to seamlessly connect independent community pharmacies with the forefront of healthcare innovation, ushering in a new era of patient-centric and cost-effective clinical research. At the…

Diversity in Clinical Trials

Diversity in Clinical Trials – How to stop talking about it and actually do it

Blog, Clinical Trials

Diversity in Clinical Trials – Background The Federal Drug Administration (FDA) issued non-compulsory guidance on clinical trial diversity to encourage diverse populations in clinical trials and improve the applicability of clinical trial results. The guidance recommends diverse clinical trial populations to better understand the safety and effectiveness of medical products across race, ethnicity, and gender.…

RxE2 announces investment from Badlands Capital

News

Fargo, ND, October 2022 RxE2 is happy to announce a recent investment from Badlands Capital. “I am so pleased to be working with Badlands Capital, especially since RxE2 is headquartered in Fargo, ND. The Badlands team truly understand what clinical trial innovation looks like and the magnitude of what RxE2 is and will accomplish, as we solve the recruitment, diversity,…

RxE2 Joins PQA

RxE2 Joins Pharmacy Quality Alliance

News

RxE2 is proud to be a member of the PQA, a non-profit organization with 250 diverse members across healthcare. Now more than ever we need to bring the practice of pharmacy into clinical trials. Incorporating PQA programs like Pharmacist Provided Care and Medication Use Quality will change the future outcomes for any clinical trial program…